Health

In a recent randomized controlled trial conducted in Vietnam and Indonesia, researchers found that the addition of dexamethasone to the treatment regimen for tuberculous (TB) meningitis in heavily immunosuppressed HIV-positive patients did not significantly improve survival or provide any other measurable benefits. The study, published in the New England Journal of Medicine, examined 520 HIV-positive
0 Comments
At the recent Psych Congress 2023, the renowned psychiatrist Dr. Peter Weiden presented a thought-provoking session titled “State of the Science: Focus on Schizophrenia.” As a clinical professor of psychiatry at the Renaissance School of Medicine at Stony Brook University in New York, Weiden delved into the latest research findings and emerging treatments in schizophrenia.
0 Comments
Obesity-related heart failure with preserved ejection fraction (HFpEF) has quickly gained recognition as a prevalent, debilitating, and deadly condition. The current treatments for heart failure, such as beta-blockers and renin-angiotensin system inhibitors, have limited efficacy in patients with obesity-related HFpEF. However, a prespecified secondary analysis of the STEP-HFpEF trial has demonstrated the potential of semaglutide
The long-term use of continuous positive airway pressure (CPAP) has shown promising results in slowing the progression of eye disease in sleep apnea patients with non-proliferative diabetic retinopathy, according to a small randomized study. However, patients who adhered to the intervention ended up with more retinal microhemorrhages. The findings from this single-center trial underscore the
A recent study conducted by researchers has provided compelling evidence of the efficacy of bimekizumab, an interleukin-17 (IL-17) blocker, in the treatment of axial spondyloarthritis (axSpA). The trial, which spanned over 52 weeks, showcased strong efficacy of bimekizumab in improving the condition of patients with axSpA. More than 60% of patients demonstrated a 40% improvement
Aspirin has long been used for secondary prevention of atherosclerotic cardiovascular disease (ASCVD). However, the use of enteric coating on aspirin pills has been a topic of debate regarding its effectiveness and safety. A recent study, known as the ADAPTABLE trial, aimed to investigate whether enteric coating impacted the outcomes of ASCVD patients. This analysis
The Food and Drug Administration (FDA) has authorized the updated Novavax COVID-19 vaccine, providing an additional option to protect against hospitalization and death from circulating variants. This protein-based shot is designed to target the XBB.1.5 strain and offers a non-mRNA alternative for the upcoming 2023-2024 season. After approving Pfizer and Moderna’s new vaccines last month
A 38-year-old woman with neurofibromatosis type 1 (NF1) presented for a routine ophthalmic examination, only to leave the Danish clinicians puzzled by the presence of choroidal Yasunari nodules in both eyes. This patient had no previous history of systemic vasculopathy, but did have a long-standing issue with peripheral retinal capillary nonperfusion in her left eye.